ScoreWhy is RPG Life Sciences Ltd ?
1
The company is Net-Debt Free
2
Poor long term growth as Net Sales has grown by an annual rate of 12.60% and Operating profit at 17.35% over the last 5 years
3
Positive results in Jun 26
- PAT(Q) Highest at Rs 30.76 cr.
- CASH AND CASH EQUIVALENTS(HY) Highest at Rs 156.78 cr
- NET SALES(Q) Highest at Rs 195.69 cr
4
With ROE of 19.3, it has a Expensive valuation with a 7.8 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 15.14%, its profits have risen by 23.1% ; the PEG ratio of the company is 1.8
5
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 1.31% over the previous quarter and collectively hold 9.63% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
6
Consistent Returns over the last 3 years
- Along with generating 15.14% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to RPG LifeScience. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is RPG LifeScience. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
RPG LifeScience.
15.48%
0.43
35.78%
Sensex
-4.36%
-0.32
13.57%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.60%
EBIT Growth (5y)
17.35%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.36
Sales to Capital Employed (avg)
1.53
Tax Ratio
25.33%
Dividend Payout Ratio
21.66%
Pledged Shares
0
Institutional Holding
9.63%
ROCE (avg)
41.11%
ROE (avg)
20.40%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
40
Industry P/E
27
Price to Book Value
7.78
EV to EBIT
33.74
EV to EBITDA
28.91
EV to Capital Employed
11.67
EV to Sales
6.11
PEG Ratio
1.75
Dividend Yield
0.84%
ROCE (Latest)
32.66%
ROE (Latest)
19.27%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Bullish
Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
PAT(Q)
Highest at Rs 30.76 cr.
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 156.78 cr
NET SALES(Q)
Highest at Rs 195.69 cr
PBDIT(Q)
Highest at Rs 43.29 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 22.12%
PBT LESS OI(Q)
Highest at Rs 36.76 cr.
-3What is not working for the Company
ROCE(HY)
Lowest at 24.18%
Loading Valuation Snapshot...
Here's what is working for RPG LifeScience.
Profit After Tax (PAT) - Quarterly
Highest at Rs 30.76 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 195.69 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 43.29 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 22.12%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 36.76 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 156.78 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
